Therefore, MAPKs and Akt signal pathway are promising targets for RA therapy, and the research and development of corresponding inhibitors for both pathways are hot spots in the research and development of RA therapeutic drugs. The gene discussed is AKT1; the disease is rheumatoid arthritis.